Akrotome receives grant for the commercialization of a topical probe for margin determination in skin cancers
AkrotomeImaging has received a $1.77M SBIR Phase II grant to assist in the clinical translation of its FIRE™ probe for margin assessment in skin cancer.
In this application, FIRE is applied ex-vivo to skin tissue that has been surgically removed. When the probe detects cancer, it glows brightly, enabling the surgeon to see active cancer on or close to the margin of the sample.
Enabling rapid and global assessment of skin cancer margins, FIRE has the potential to reduce repeat surgeries by ensuring complete removal of all cancer while sparing healthy tissue.
CD ComputaBio, a reputable computational service provider in the field of biology, has proudly announced the launch of its Antibody De Novo Design technology, marking a pivotal moment in the field of drug discovery and development. This service harnesses the power of AI to engineer antibodies with unmatched precision, paving the way for targeted therapies, personalized medicine, and cutting-edge protein drug design.
Antibody-based therapies have witnessed unprecedented success in treating a wide array of...
Prominent within the field of computational biology, CD ComputaBio, unveils its cutting-edge Antibody Drug Design Services and Antibody Development solutions. Driven by an unwavering commitment to advancing precision medicine, the company stands at the forefront of redefining therapeutic strategies and expediting drug discovery processes, fostering innovation within the healthcare industry.
In the realm of Antibody Drug Design Services, CD ComputaBio employs sophisticated computational methodologies to engineer...
CD Formulation, a reputable contract research organization (CRO) based in New York, has become a trusted partner for many pharmaceutical companies around the world seeking innovative drug formulation methods and solutions. Recently, CD Formulation further strengthened its role as a drug delivery expert by demonstrating its expertise in the development of cutting-edge CAR-T and CAR-NK cells for drug delivery systems.
The Marketing Director of CD Formulation stated, "With our wealth of expertise in drug delivery...
CD Genomics, a trailblazing genomics and bioinformatics services provider, is delighted to announce the launch of the Long Amplicon Analysis (LAA) service, a mature genomic research method that promises to revolutionize the field. With LAA, scientists can now explore intricate genomic landscapes, facilitating groundbreaking discoveries and advancements in various branches of genomics.
Long Amplicon Analysis represents a cutting-edge technique that enables the efficient amplification and sequencing of extended...
Creative Proteomics, a leading provider of proteomics and metabolomics services, is proud to announce the launch of its state-of-the-art Exosome Isolation and Purification Service. This innovative service is designed to meet the increasing demand for high-quality exosomes in the field of biomedical research and therapeutic development.
Exosomes, small extracellular vesicles released by cells, have emerged as crucial mediators of intercellular communication. They play a significant role in various physiological...
Customer comments
No comments were found for Akrotome has been awarded $1.77M by The National Cancer Institute. Be the first to comment!
